K2M Group (NASDAQ:KTWO) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.

Several other equities research analysts have also recently weighed in on the company. Zacks Investment Research upgraded K2M Group from a “sell” rating to a “hold” rating in a report on Thursday, January 25th. Barclays reiterated a “buy” rating and issued a $25.00 price objective on shares of K2M Group in a report on Tuesday, January 9th. Needham & Company LLC increased their price objective on K2M Group from $20.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, January 9th. Wells Fargo & Co cut K2M Group from an “outperform” rating to a “market perform” rating and set a $23.00 price objective for the company. in a report on Monday, December 4th. Finally, Oppenheimer reiterated a “buy” rating and issued a $24.00 price objective on shares of K2M Group in a report on Friday, November 10th. One analyst has rated the stock with a sell rating, three have given a hold rating and nine have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $24.50.

Shares of K2M Group (NASDAQ:KTWO) opened at $18.53 on Thursday. The firm has a market capitalization of $798.98, a PE ratio of -19.10 and a beta of 1.47. K2M Group has a fifty-two week low of $16.44 and a fifty-two week high of $25.99. The company has a current ratio of 3.06, a quick ratio of 1.67 and a debt-to-equity ratio of 0.29.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Goldman Sachs Group Inc. lifted its holdings in K2M Group by 82.3% in the 2nd quarter. Goldman Sachs Group Inc. now owns 211,585 shares of the medical device company’s stock worth $5,154,000 after buying an additional 95,548 shares during the period. Ameriprise Financial Inc. purchased a new stake in K2M Group in the 2nd quarter worth approximately $1,664,000. Oppenheimer Asset Management Inc. bought a new position in shares of K2M Group in the 3rd quarter worth approximately $347,000. Prudential Financial Inc. raised its position in shares of K2M Group by 12.3% in the 3rd quarter. Prudential Financial Inc. now owns 303,930 shares of the medical device company’s stock worth $6,446,000 after acquiring an additional 33,200 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of K2M Group by 83.0% in the 3rd quarter. Bank of New York Mellon Corp now owns 380,637 shares of the medical device company’s stock worth $8,073,000 after acquiring an additional 172,650 shares in the last quarter. Institutional investors and hedge funds own 98.84% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “K2M Group (KTWO) Rating Lowered to Hold at BidaskClub” was originally posted by Watch List News and is the property of of Watch List News. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright law. The legal version of this article can be read at https://www.watchlistnews.com/k2m-group-ktwo-rating-lowered-to-hold-at-bidaskclub/1857988.html.

About K2M Group

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.